medroxyprogesterone acetate has been researched along with Libman-Sacks Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alpers, CE; Clark, EA; Elkon, KB; Hudkins, KL; Hughes, GC; Martin, D; Zhang, K | 1 |
| Weisberg, E | 1 |
| Cravioto, MD; Durand-Carbajal, M; Jiménez-Santana, L; Lara-Reyes, P; Sánchez-Guerrero, J; Seuc, AH | 1 |
| Frederiksen, MC | 1 |
| Keisler, LW; Kier, AB; Walker, SE | 1 |
1 review(s) available for medroxyprogesterone acetate and Libman-Sacks Disease
| Article | Year |
|---|---|
Depot medroxyprogesterone acetate contraception in women with medical problems.
Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Diabetes Mellitus; Epilepsy; Female; Humans; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Pregnancy; Smoking | 1996 |
1 trial(s) available for medroxyprogesterone acetate and Libman-Sacks Disease
| Article | Year |
|---|---|
Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
Topics: Adult; Aged; Analysis of Variance; Chi-Square Distribution; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor Analysis, Statistical; Female; Humans; Kaplan-Meier Estimate; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Menopause; Mexico; Middle Aged; Patient Selection; Principal Component Analysis; Progestins; Risk Assessment; Surveys and Questionnaires; Time Factors; Treatment Outcome; Vasomotor System | 2011 |
3 other study(ies) available for medroxyprogesterone acetate and Libman-Sacks Disease
| Article | Year |
|---|---|
Decrease in glomerulonephritis and Th1-associated autoantibody production after progesterone treatment in NZB/NZW mice.
Topics: Animals; Autoantibodies; B7-2 Antigen; Complement C3; Disease Models, Animal; DNA; Dose-Response Relationship, Drug; Female; Glomerulonephritis; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Mice; Mice, Inbred NZB; Progesterone; Proteinuria; Th1 Cells | 2009 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Effects of prolonged administration of the 19-nor-testosterone derivatives norethindrone and norgestrel to female NZB/W mice: comparison with medroxyprogesterone and ethinyl estradiol.
Topics: Animals; Antibodies, Antinuclear; Contraceptives, Oral, Hormonal; Disease Models, Animal; Ethinyl Estradiol; Female; Longevity; Lupus Erythematosus, Systemic; Lupus Nephritis; Medroxyprogesterone Acetate; Mice; Mice, Inbred NZB; Norethindrone; Norgestrel; Time Factors; Urinary Tract | 1991 |